共 14 条
- [3] The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 30
- [4] Study Design: Effects Of Long Term Tobramycin Inhalation Solution (tis) Once Daily On Exacerbation Rate In Patients With Non-Cystic Fibrosis Bronchiectasis. A Double Blind, Randomized, Placebo And Tis Twice Daily (open Label) Controlled Trial. The Battle Study AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
- [5] Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials BMC INFECTIOUS DISEASES, 2015, 15
- [9] Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BLESS Randomized Controlled Trial JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12): : 1260 - 1267